John L. Keltner

John L. Keltner's AcademicInfluence.com Rankings

John L. Keltner

Medical

#3344

World Rank

#3812

Historical Rank

Ophthalmology

#70

World Rank

#90

Historical Rank

medical Degrees

Download Badge

Medical

John L. Keltner's Degrees

Doctorate Medicine University of California, San Francisco

Why Is John L. Keltner Influential?

(Suggest an Edit or Addition)

(See a Problem?)

John L. Keltner's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. (2002) (3368)
The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. (2002) (2516)
A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis (1992) (973)
Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. (2008) (469)
Incidence of visual field loss in 20,000 eyes and its relationship to driving performance. (1983) (429)
High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. (2003) (394)
Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. (2014) (367)
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. (1992) (335)
The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. (2014) (312)
Psychosocial aspects of strabismus study. (1993) (282)
Classification of visual field abnormalities in the ocular hypertension treatment study. (2000) (266)
The cancer-associated retinopathy antigen is a recoverin-like protein. (1992) (231)
Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. (1989) (226)
Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. (2004) (215)
Clinical and Immunologic Characteristics of Melanoma-Associated Retinopathy Syndrome: Eleven New Cases and a Review of 51 Previously Published Cases (2001) (211)
Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. (1993) (208)
In vivo imaging of the photoreceptor mosaic in retinal dystrophies and correlations with visual function. (2006) (169)
Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group. (2000) (169)
Photoreceptor degeneration. Possible autoimmune disorder. (1983) (158)
Skip areas in temporal arteritis. (1976) (122)
Cancer-associated retinopathy. (1987) (119)
Management and monitoring of cancer-associated retinopathy. (1992) (114)
Evidence of outer retinal changes in glaucoma patients as revealed by ultrahigh-resolution in vivo retinal imaging (2010) (113)
Visual function 5 years after optic neuritis: Experience of the optic neuritis treatment trial (1997) (108)
The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study. (2006) (105)
Effects of target size and eccentricity on visual detection and resolution (1978) (105)
Giant-cell arteritis. Signs and symptoms. (1982) (103)
Optic nerve sheath decompression. How does it work? Has its time come? (1988) (101)
Dural and carotid cavernous sinus fistulas. Diagnosis, management, and complications. (1987) (99)
Characteristics of the normative database for the Humphrey matrix perimeter. (2005) (99)
Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy. (1993) (96)
Botulinum A toxin (Oculinum) in ophthalmology. (1991) (94)
Changes in cellular structures revealed by ultra-high resolution retinal imaging in optic neuropathies. (2008) (93)
Neurologic impairment 10 years after optic neuritis. (2004) (91)
Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features. (2014) (89)
Acute optic neuropathy in older patients. (1973) (89)
Baseline visual field characteristics in the ocular hypertension treatment study. (2002) (86)
The California syndrome. Functional visual complaints with potential economic impact. (1985) (84)
Visual function, driving safety, and the elderly. (1987) (81)
Visual field loss in migraine. (1989) (80)
Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years. (2010) (80)
Variability of quantitative automated perimetry in normal observers. (1986) (79)
Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability. (2014) (79)
Outer retinal abnormalities associated with inner retinal pathology in nonglaucomatous and glaucomatous optic neuropathies (2011) (76)
The ultimate diagnoses of patients undergoing temporal artery biopsies. (1984) (73)
Cancer-associated retinopathy vs recoverin-associated retinopathy. (1998) (73)
Multifocal electroretinogram: age-related changes for different luminance levels (2002) (71)
The Idiopathic Intracranial Hypertension Treatment Trial: Design Considerations and Methods (2014) (71)
Visual Field Profile of Optic Neuritis: One-Year Follow-up in the Optic Neuritis Treatment Trial (1994) (66)
Long- and short-term variability of automated perimetry results in patients with optic neuritis and healthy subjects. (1998) (65)
Suprathreshold static perimetry. Initial clinical trials with the Fieldmaster automated perimeter. (1979) (63)
Optic nerve decompression. A clinical pathologic study. (1977) (61)
Quality control functions of the Visual Field Reading Center (VFRC) for the Optic Neuritis Treatment Trial (ONTT). (1993) (59)
Comparison of central and peripheral visual field properties in the optic neuritis treatment trial. (1996) (58)
Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial. (2015) (56)
Palatal myoclonus associated with abnormal ocular and extremity movements. A polygraphic study. (1972) (56)
Eye Movement Disorders (1975) (54)
Mycosis fungoides. Intraocular and central nervous system involvement. (1977) (51)
Automated suprathreshold static perimetry. (1980) (51)
Short-wavelength automated perimetry in neuro-ophthalmologic disorders. (1995) (49)
Ocular dyskinesia in cerebellar disease. Evidence for the similarity of opsoclonus, ocular dysmetria and flutter-like oscillations. (1972) (49)
Suprathreshold static perimetry in glaucoma and other optic nerve disease. (1979) (49)
Paraneoplastic Optic Neuropathy and Autoantibody Production in Small‐Cell Carcinoma of the Lung (1998) (48)
Visual Field Quality Control in the Ocular Hypertension Treatment Study (OHTS) (2005) (47)
Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study. (2005) (47)
Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study. (2006) (47)
The 22-kDa antigen in optic nerve and retinal diseases. (1999) (46)
CONFIRMATION OF VISUAL FIELD ABNORMALITIES IN THE OCULAR HYPERTENSION TREATMENT STUDY (OHTS) (1999) (46)
Optimal rates of movement for kinetic perimetry. (1987) (45)
Fourier-Domain Optical Coherence Tomography and Adaptive Optics Reveal Nerve Fiber Layer Loss and Photoreceptor Changes in a Patient With Optic Nerve Drusen (2008) (44)
Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial. (1995) (43)
Correlation of color vision deficits and observable changes in the optic disc in a population of ocular hypertensives. (1984) (43)
Walsh & Hoyt's Clinical Neuro-Ophthalmology, Volume 4 (1992) (43)
Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study. (2010) (42)
Comparison of Retinal Nerve Fiber Layer and Central Macular Thickness Measurements Among Five Different Optical Coherence Tomography Instruments in Patients With Multiple Sclerosis and Optic Neuritis (2011) (40)
Mass visual field screening in a driving population. (1980) (40)
Intraperitoneal cultivation of small-cell carcinoma induces expression of the retinal cancer-associated retinopathy antigen. (1993) (39)
Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) (2016) (39)
Visual evoked response. (1977) (39)
Photogrammetry of the optic disc in glaucoma and ocular hypertension with simultaneous stereo photography. (1979) (37)
Abnormalities of the pupil and visual-evoked potential in quinine amblyopia. (1980) (36)
Leber hereditary optic neuropathy possibly triggered by exposure to tire fire. (2006) (35)
Computer analysis of the optic cup in glaucoma. (1985) (34)
Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). (2014) (33)
Risk Factors for Fellow Eye Involvement in Nonarteritic Anterior Ischemic Optic Neuropathy (2019) (29)
Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial (2016) (29)
Strabismus surgery in adults. Functional and psychosocial implications. (1994) (29)
Visual function and driving safety. (1992) (29)
Screening for visual field abnormalities with automated perimetry. (1983) (27)
Opsoclonus with amitriptyline overdose (1979) (26)
A red eye and high intraocular pressure. (1987) (25)
Antibody indications of secondary and superimposed retinal hypersensitivity in retinitis pigmentosa. (1991) (25)
Comparative evaluation of the Autofield-I, CFA-120, and Fieldmaster Model 101-PR automated perimeters. (1980) (25)
Effectiveness of automated perimetry in following glaucomatous visual field progression. (1982) (23)
Visualization of lipofuscin accumulation in Stargardt macular dystrophy by high-resolution Fourier-domain optical coherence tomography. (2007) (23)
Computer analysis of visual field loss and optimization of automated perimetric test strategies. (1981) (21)
Acute optic neuropathy. Treatment with diphenylhydantoin. (1974) (21)
Automated and manual perimetry-a six-year overview. Special emphasis on neuro-ophthalmic problems. (1984) (21)
Undiagnosed Papilledema in a Morbidly Obese Patient Population: A Prospective Study (2011) (20)
Acuity profile perimetry: description of technique and preliminary clinical trials. (1979) (20)
Normal pupil size and anisocoria in newborn infants. (1990) (20)
Neuro‐Ophthalmic Signs in Pontine Lesions (1979) (19)
Comparison of photographic techniques and films used in stereophotogrammetry of the optic disk. (1979) (18)
Active giant cell arteritis with cerebral involvement. Findings following four years of corticosteroid therapy. (1976) (18)
A case of autoimmune-related retinopathy and optic neuropathy syndrome treated by autologous nonmyeloablative hematopoietic stem cell transplantation. (2009) (17)
Abducting nystagmus in the medial longitudinal fasciculus (MLF) syndrome- internuclear ophthalmoplegia (INO). (1974) (16)
Comparative material on automated and semiautomated perimeters--1986. (1981) (16)
Myotonic pupils in Charcot-Marie-Tooth disease. Successful relief of symptoms with 0.025% pilocarpine. (1975) (15)
Quantitative office perimetry. (1985) (15)
Sensitivity and specificity of the Humphrey Matrix to detect homonymous hemianopias. (2008) (15)
Intermittent pupillary dilation in a young woman. (1986) (15)
Experimental internuclear ophthalmoplegia. (1977) (14)
Pancreatic neuroendocrine paraneoplastic optic neuropathy: confirmation with antibody to optic nerve and hepatic metastasis. (2013) (14)
Humphrey Matrix perimetry in optic nerve and chiasmal disorders: comparison with Humphrey SITA standard 24-2. (2008) (13)
Automated kinetic perimetry: an efficient method of evaluating peripheral visual field loss. (1987) (12)
The monocular shimmers--your patient isn't deluded! (1983) (12)
Current status of automated perimetry. Is the ideal automated perimeter available? (1986) (12)
Corneal anesthesia after percutaneous radiofrequency trigeminal rhizotomy. A retrospective study. (1982) (12)
Effect of diphenylhydantoin in ischemic optic neuritis. (1972) (11)
The variable expressivity of a family with central areolar pigment epithelial dystrophy. (1996) (11)
Capabilities and Limitations of Automated Suprathreshold Static Perimetry (1981) (10)
Is Graves ophthalmopathy a preventable disease? (1998) (10)
Comments on automated perimetry papers. (1979) (10)
Subspecialty fellowships: standardizing and enhancing the educational experience. (2007) (10)
Static and acuity profile perimetry at various adaptation levels (1981) (10)
Assessment of Cumulative Incidence and Severity of Primary Open-Angle Glaucoma Among Participants in the Ocular Hypertension Treatment Study After 20 Years of Follow-up. (2021) (10)
Stratus OCT Quality Control in Two Multi-Centre Multiple Sclerosis Clinical Trials (2011) (10)
Paraneoplastic retinopathy syndrome. (1993) (9)
Microstructural Abnormalities Revealed by High Resolution Imaging Systems in Central Macular Arteriovenous Malformation. (2010) (9)
Automated perimetry I. A consumer's guide. (1981) (9)
Automated and Manual Periemetry-A Six-Year Overview (1984) (9)
Virus-simulating structures in the optic nerve head in Creutzfeldt-Jakob disease. (1979) (8)
The California syndrome. A threat to all. (1988) (8)
Sugarplum fairies. Visual hallucinations. (1982) (8)
JAWS (Joint Automated Weighting Statistic): a method of converting results between automated perimeters (1987) (8)
Role of electrophysiologic testing in the preoperative evaluation of corneal transplant patients. (1984) (8)
Thrombosis of the lateral transverse sinus with papilledema. (1993) (8)
New Test Procedures for the Squid Automated Perimeter (1985) (8)
The disc that really isn't (hypoplastic disc syndrome) (1985) (7)
Optic neuritis--etiology? (1980) (7)
Topography of early visual field defects in computerized perimetry: by E. Gramer. Klin Monatsbl Augenheilkd 180: 515–523, 1982 (1983) (7)
Short-Wavelength Automated Perimetry in Neuro-Ophthalmologic Disorders (1996) (6)
Acquired diplopia. Not always a neurologic problem. (1982) (6)
Automated perimetry. II. Devices manufactured in the United States and abroad. (1981) (5)
Neuro-ophthalmology for the pediatrician. (1977) (5)
Branch artery occlusion in a young woman. (1985) (5)
Corneal sensitivity after percutaneous radiofrequency trigeminal rhizotomy: a quantitative study. (1982) (5)
Linear nevus sebaceous syndrome. (1993) (5)
Unilateral blurred vision and dilated retinal veins. (1987) (4)
Total third nerve paralysis. Recovery in a case of meningococcic meningitis. (1972) (4)
Preliminary Examination of the Squid Automated Perimeter (1983) (4)
Four years of ophthalmology training. Has its time come? (1990) (4)
Giant cell (temporal) arteritis. The differential diagnosis. (1979) (4)
The Neuro-Ophthalmology Research Disease Investigator Consortium (NORDIC). (2009) (4)
Accreditation of fellowship programs gets a deferment (2002) (3)
Acuity profile perimetry in a unique case of bilateral central serous retinopathy (1980) (3)
Neuro-ophthalmologic dilemma: chronic optic neuritis? (1978) (3)
Visual Fields and Retinal Nerve Fiber Layer Thickness After Boston Keratoprosthesis (2010) (3)
Progressive visual loss with normal examination. A conundrum. (1986) (3)
Clinical challenges. Popping eyes (1989) (3)
Fellowship training in neuro-ophthalmology in the United States. (2015) (3)
Ophthalmology-epitomes of progress: lasers in ophthalmology. (1979) (3)
Rapidly Progressive Homonymous Hemianopia in the Heidenhain Variant of Creutzfeldt-Jakob Disease (2012) (2)
Preliminary Clinical Trials with the Humphrey Field Analyzer (1985) (2)
Comparison of Retinal Nerve Fiber Layer Thickness and Macular Thickness/Volume Among Patients with Relapsing-Remitting Multiple Sclerosis: Baseline Data from a Phase 3 Trial of Fingolimod (2011) (2)
Frequency Doubling Technology Perimetry 2 (24-2) in the Evaluation of Homonymous Hemianopias (2003) (2)
Positive Auto-Antibody Activity With Retina and Optic Nerve in Smokers and Non-Smokers: The Controversy Continues. (2015) (2)
Acute cerebellar ataxia of childhood and optic neuritis with retrochiasmal involvement. (1982) (2)
Properties of Scotomata in Glaucoma and Optic Nerve Disease: Computer Analysis (1983) (2)
PARANEOPLASTIC RETINOPATHIES AND OPTIC NEUROPATHIES VS. (NON-CANCER) AUTOIMMUNE RELATED RETINOPATHY AND OPTIC NEUROPATHY (ARRON SYNDROME) (2010) (2)
Static and Acuity Profile Perimetry in Optic Neuritis (1981) (2)
Abducting nystagmus in the medial longitudinal fasciculus (MLF) syndrome (internuclear ophthalmoplegia (INO)). (1973) (2)
Pseudotumor cerebri. (1979) (2)
Double vision, visual loss, and an enhancing orbital apex. (1988) (2)
Progressive visual loss associated with peculiar disc swelling. (1979) (2)
An Atypical Case of Rapidly Progressive Heidenhain-Variant of Creutzfeldt-Jakob Disease (HvCJD), Misdiagnosed as Posterior Reversible Encephalopathy Syndrome (PRES) (2011) (2)
Correlations between Peripheral Visual Function and Driving Performance (1983) (2)
In vivo High–Resolution Imaging of Retinal Dystrophy With Different Adaptive Optics Imaging Modalities (2006) (1)
The incidence of ‘normal antibody activity’ with retinain a population of 100 normal individuals (2004) (1)
Comparative material on automated and semiautomated perimeters-1983. (1983) (1)
Comparison of Optic Nerve and Macular Thickness Among Commercially Available Fourier-Domain and Time-Domain Optical Coherence Tomography Instruments in Patients With Multiple Sclerosis and / or Optic Neuritis (2009) (1)
Longitudinal and Cross-Sectional Analyses of Visual Field Progression in the Ocular Hypertension Treatment Study (OHTS) (2007) (1)
Automated Visual Field Plotters vs Tangent Screen Kinetic Perimetry-Reply (1980) (1)
Frequency Doubling Perimetry for Optic Nerve and Chiasmal Neuro-Ophthalmic Disorders (2003) (1)
Classification of Glaucomatous Visual Field Abnormalities In the Ocular Hypertension Treatment Study (OHTS) (2003) (1)
"Squeezing eyes." A clinical pathological conference. (1981) (1)
Types of Visual Field Abnormalities that Subsequently Become Visual Field Primary Open–Angle Glaucoma in the Ocular Hypertension Treatment Study (OHTS) (2004) (1)
Clinical Application of Adaptive Optics - Optical Coherence Tomography (AO - OCT) in Studying of Micro-Structural Changes Associated With Macular Pathologies (2008) (1)
Comparative material on automated and semiautomated perimeters--1985. (1985) (1)
Correlation Between Functional Vision Tests and in vivo Images of Retinal Diseases Obtained With the UC–Davis Adaptive Optics Ophthalmoscope (2005) (1)
Non-Linear Dimensionality Reduction of Visual Field Data in Chronic Open Angle Glaucoma (2008) (1)
Expert Evaluation of Visual Fields in Glaucoma: Enabling Remote Collaborations Through a Web-based Application (2009) (0)
Application of Brusini’s Glaucoma Staging System 2 (GSS 2) to Glaucomatous Visual Fields in the Ocular Hypertension Treatment Study (OHTS) (2008) (0)
Incidence of Glaucomatous Visual Field Loss Subsequent to Initial Glaucomatous Optic Disc Deterioration in the Ocular Hypertension Treatment Study (OHTS) (2010) (0)
Homonymous Hemianopia and Disc Pallor After Severe Head Injury (1984) (0)
Comparison of Retinal Nerve Fiber Layer Thickness Measurement by Quadrant Among Commercially Available Optical Coherence Tomography Instruments in Patients With Optic Neuritis and/or Multiple Sclerosis (2010) (0)
PL-112 Higher than expected prevalence of asymptomatic pseudotumor cerebri: A prospective trial of 532 bariatric patients (2011) (0)
Optical Coherence Tomography in Neuro–Ophthalmologic Optic Nerve Disease (2006) (0)
A regional course to update the practicing specialist. (1979) (0)
Ophthalmology-epitomes of progress: automated perimetry. (1979) (0)
North american neuro-ophthalmology fellowships to begin voluntary participation in standard guidelines program in july 2006 (2006) (0)
Visual Field Defect Characteristics in Cases of Hyperprolactinaemia (1981) (0)
Title In vivo imaging of the photoreceptor mosaic in retinal dystrophies and correlations with visual function Permalink (2006) (0)
Normal Aging Effects for Two Forms of Frequency Doubling Technology (fdt) Perimetry Using a 24-2 Stimulus Presentation Pattern (2003) (0)
1 clinical vision testing: A survival guide (1994) (0)
New international classification of diseases (ICD-11) needs NANOS input. (2009) (0)
The Ocular Hypertension Treatment Study: Aging and Reliability of Visual Fields (2018) (0)
Asymptomatic Papilledema in Morbidly Obese Patients: A Prospective Study (2009) (0)
Medicine in the future. (1986) (0)
To Image Or Not To Image (1988) (0)
Visual Fields in Optic Neuritis-Reply (1993) (0)
THE OCULAR HYPERTENSIVE TREATMENT STUDY.: 9:45 - 10:00 (2002) (0)
Acknowledgement of Referees We would like to thank the following people, who have contributed their time and talents to the peer review of outlines and manuscripts published from January 2003 through December 2003 (2003) (0)
Symposium on ear diseases. II. Vestibular evaluation and the brain stem (1972) (0)
Undiagnosed Idiopathic Intracranial Hypertension in a Population of Morbidly Obese Patients: A Prospective Study (2010) (0)
Penetrating keratoplasty in the management of posterior amorphous corneal dystrophy (II) (1990) (0)
Impaired visual flicker discrimination with hypothalmic pituitary disease. by M.L. Daley and D.M. Cook. Arch Neurol 40: 643-644, 1983 (1984) (0)
Lid retraction or no lid retraction in optic neuropathy with proptosis. (1985) (0)
Glaucoma Detection in Boston Keratoprosthesis Patients (2011) (0)
Proton Beam Therapy of Uveal Melanomas (2017) (0)
Classification of Baseline VIsual FIeld Results in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) (2014) (0)
Fields of OHTS: The Ocular Hypertension Treatment Study (2011) (0)
Therapy with Botulinum Toxin (1995) (0)
Risk Factors for Fellow Eye Involvement in Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION): Optic Disc Drusen (ODD) and Continuous Positive Airway Pressure (CPAP) Non-compliance (2018) (0)
Orbital Disease. Imaging and Analysis (1994) (0)
Retinal Nerve Fiber Layer Thickness defines Multiple Sclerosis Patients at Risk of Future Disease Progression (S33.003) (2017) (0)
OCT Quality Control in Two Multi-Center Multiple Sclerosis (MS) Therapeutic Trials (2010) (0)
Manual of Visual Fields (1991) (0)
RPE-Hypersensitivity: Complement Involvement in Serum from Patients with Age-Related Macular Degenerations (2002) (0)
Central visual dysfunction with disc swelling. (1981) (0)
Retinal Degeneration in an Adult With Long–Chain 3–Hydroxy Acyl–CoA Dehydrogenase Deficiency (2005) (0)
Variability and fatigue effects for automated perimetry in optic neuritis patients (1996) (0)
Pluses and minuses of relaxing fixation loss criterion (1996) (0)
GRAVES OPHTHALMOPATHY. AUTHOR'S REPLY (1999) (0)
Electrodiagnostic Testing of the Visual System-A Clinical Guide (1991) (0)
Microstructural Abnormalities Associated With Central Macular Arteriovenous Malformation Documented by Fourier-Domain Optical Coherence Tomography (2007) (0)
Archives of Ophthalmology (1918) (0)
The Characterization and Comparison of OHTS Abnormal Visual Field Classifications using the 24-2 vs. the 30-2 Testing Strategies (2002) (0)
Graves ophthalmopathy [1] (multiple letters) (1999) (0)
Current Neuro-Ophthalmology (1992) (0)
Benefits of Strabismus Surgery in Patients With One Blind Eye-Reply (1995) (0)
Radiology of the Eye and Orbit (Modern Neuroradiology, Vol 4) (1991) (0)
Steroid-Responsive Optic Neuropathy (SRON) in Anti-neutrophil Cytoplasmic Antibody–Negative Wegener Granulomatosis with False-Positive Indicators of Giant Cell Arteritis and Sarcoidosis (2010) (0)
EFFECT OF D1PHENYLHYDANTOIN IN ISCHEMIC OPTIC NEURI1TIS* (2005) (0)
Neuro-ophthalmology, for the pediatrician. (1977) (0)
A Comparison of Full Threshold and Swedish Interactive Threshold Algorithms (SITA) Testing Procedures in the Ocular Hypertension Treatment Study (OHTS) (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With John L. Keltner?

John L. Keltner is affiliated with the following schools:

University of California, Davis